280 related articles for article (PubMed ID: 33760165)
1. miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review).
Mu H; Zhang W; Qiu Y; Tao T; Wu H; Chen Z; Xu G
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760165
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Bertoli G; Cava C; Castiglioni I
Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
6. Computational Identification of Sex-Biased Biomarker MicroRNAs and Genes Associated with Immune Infiltration in Breast Cancer.
Li EW; Bai Y
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33919884
[TBL] [Abstract][Full Text] [Related]
7. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
Bertoli G; Cava C; Castiglioni I
Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA and cyclooxygenase-2 in breast cancer.
Li W; Zhang Z; Wang B; Liang N; Zhou Q; Long S
Clin Chim Acta; 2021 Nov; 522():36-44. PubMed ID: 34389281
[TBL] [Abstract][Full Text] [Related]
9. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
10. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
11. Identification of miRNA Master Regulators in Breast Cancer.
Martinez-Gutierrez AD; Cantú de León D; Millan-Catalan O; Coronel-Hernandez J; Campos-Parra AD; Porras-Reyes F; Exayana-Alderete A; López-Camarillo C; Jacobo-Herrera NJ; Ramos-Payan R; Pérez-Plasencia C
Cells; 2020 Jul; 9(7):. PubMed ID: 32635183
[TBL] [Abstract][Full Text] [Related]
12. Candidate miRNAs in human breast cancer biomarkers: a systematic review.
Adhami M; Haghdoost AA; Sadeghi B; Malekpour Afshar R
Breast Cancer; 2018 Mar; 25(2):198-205. PubMed ID: 29101635
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Networks in Breast Cancer Cells.
Tahiri A; Aure MR; Kristensen VN
Methods Mol Biol; 2018; 1711():55-81. PubMed ID: 29344885
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer.
Wang JJ; Huang YQ; Song W; Li YF; Wang H; Wang WJ; Huang M
Oncol Rep; 2019 Dec; 42(6):2572-2582. PubMed ID: 31638237
[TBL] [Abstract][Full Text] [Related]
16. The Regulatory Role of MicroRNAs in Breast Cancer.
Loh HY; Norman BP; Lai KS; Rahman NMANA; Alitheen NBM; Osman MA
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590453
[TBL] [Abstract][Full Text] [Related]
17. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
18. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
20. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
Eissa S; Matboli M; Shehata HH
Transl Res; 2015 Mar; 165(3):417-27. PubMed ID: 25445205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]